In the DepMap cohort, approximately half of the VHL mutant ccRCC lines are sensitive to BHLHE40 KO, and interestingly, this includes all the SMARCB1 mutant lines (Figure 5F). Here, SMARCB1 is linked to nonpapillary renal cell carcinoma.